The Brazilian FDA (ANVISA) issues Rule #168/2017 on procedures for pharmaceutical patent applications under Art. 229-C of the Patent Statute. New rule implements Interagency Ordinance #1 of 2017.
(Federal Register of August 10 th , 2017)The ANVISA published at the Federal Register #153 today, August 10 th , 2017, Rule #168/2017 which establishes the procedures to be followed by the Agency during the prior approval analysis of patent applications claiming pharmaceutical products and processes under the authority of art. 229-C of the 1996 […]